• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰乙醇胺增强因子VIIa-组织因子活性:增强对磷脂酰丝氨酸的敏感性。

Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine.

作者信息

Neuenschwander P F, Bianco-Fisher E, Rezaie A R, Morrissey J H

机构信息

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City 73104, USA.

出版信息

Biochemistry. 1995 Oct 31;34(43):13988-93. doi: 10.1021/bi00043a004.

DOI:10.1021/bi00043a004
PMID:7577996
Abstract

The effect of phosphatidylethanolamine (PE) on the activity of the factor VIIa-tissue factor complex (fVIIa-TF) has been examined with respect to plasma clotting activity and activation of factor X (fX) in a purified system. Vesicles prepared by relipidating membrane-anchored TF (dcTF; TF1-244, lacking the C-terminal cytoplasmic tail) into phospholipid vesicles containing 6 mol % phosphatidylserine (PS) and increasing levels of PE up to 40 mol % (the balance consisting of phosphatidylcholine) were found to progressively shorten TF-initiated clotting in normal human plasma to levels comparable to those observed using dcTF relipidated with cephalin. The shortened clotting times were at least in part due to the ability of PE-containing membranes to better support the activation of fX by the fVIIa.TF complex, as vesicles with increased PE content yielded progressively higher initial rates of fX activation. Surprisingly, PE substantially altered the sensitivity of fX activation to low levels of PS, yielding near-maximal rates of activation at only 3 mol % PS compared to 15-20 mol % PS required in the absence of PE. The effect of PE was not synergistic with that of PS since PE did not increase fX activation rates at high levels of PS (20 mol %). Examination of the kinetic parameters for fX activation revealed that the majority of the effect of PE was in decreasing the apparent Km for fX.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在一个纯化系统中,针对血浆凝血活性和因子X(fX)的激活,研究了磷脂酰乙醇胺(PE)对因子VIIa-组织因子复合物(fVIIa-TF)活性的影响。通过将膜锚定组织因子(dcTF;TF1-244,缺少C末端细胞质尾巴)重新脂质化到含有6摩尔%磷脂酰丝氨酸(PS)且PE水平逐渐增加至40摩尔%(其余为磷脂酰胆碱)的磷脂囊泡中所制备的囊泡,被发现可使正常人血浆中由TF引发的凝血逐渐缩短至与使用脑磷脂重新脂质化的dcTF所观察到的水平相当。凝血时间缩短至少部分归因于含PE的膜能够更好地支持fVIIa.TF复合物对fX的激活,因为PE含量增加的囊泡产生了逐渐升高的fX激活初始速率。令人惊讶的是,PE显著改变了fX激活对低水平PS的敏感性,在仅3摩尔%PS时就能产生接近最大激活速率,而在没有PE的情况下需要15 - 20摩尔%PS。PE的作用与PS并非协同作用,因为在高水平PS(20摩尔%)时PE并未增加fX激活速率。对fX激活动力学参数的研究表明,PE的大部分作用在于降低fX的表观Km。(摘要截断于250字)

相似文献

1
Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine.磷脂酰乙醇胺增强因子VIIa-组织因子活性:增强对磷脂酰丝氨酸的敏感性。
Biochemistry. 1995 Oct 31;34(43):13988-93. doi: 10.1021/bi00043a004.
2
Phosphatidylserine and phosphatidylethanolamine regulate the structure and function of FVIIa and its interaction with soluble tissue factor.磷脂酰丝氨酸和磷脂酰乙醇胺调节 FVIIa 的结构和功能及其与可溶性组织因子的相互作用。
Biosci Rep. 2021 Feb 26;41(2). doi: 10.1042/BSR20204077.
3
Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.凝血因子VIIa和组织因子的膜相互作用区域的作用。凝血因子VIIa的γ-羧基谷氨酸(Gla)结构域对于与组织因子的结合并非必需,但对凝血因子X的激活很重要。
J Biol Chem. 1994 Mar 18;269(11):8007-13.
4
Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.组织因子-因子VIIa对底物的识别。组织因子的赖氨酸165和赖氨酸166残基与因子X富含γ-羧基谷氨酸结构域相互作用的证据。
J Biol Chem. 1996 Sep 6;271(36):21752-7. doi: 10.1074/jbc.271.36.21752.
5
Lipid-bound factor Xa regulates tissue factor activity.脂质结合的凝血因子Xa调节组织因子活性。
Biochemistry. 2007 May 22;46(20):6134-40. doi: 10.1021/bi700136a. Epub 2007 May 1.
6
The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles.成纤维细胞表面表达的组织因子促凝活性可被组织因子阴性细胞外囊泡所增强。
PLoS One. 2020 Oct 8;15(10):e0240189. doi: 10.1371/journal.pone.0240189. eCollection 2020.
7
Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.磷脂表面调节底物向组织因子:VIIa的递送以及产物的清除。
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):194-8. doi: 10.1016/j.bcmd.2005.12.032. Epub 2006 Mar 9.
8
Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation.直接扩增组织因子:胆汁酸对因子 VIIa 的促凝活性驱动肝内凝血。
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2038-2048. doi: 10.1161/ATVBAHA.119.313215. Epub 2019 Aug 15.
9
The interaction of human factor VIIa with tissue factor.人凝血因子VIIa与组织因子的相互作用。
J Biol Chem. 1992 Nov 25;267(33):23696-706.
10
Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine.中凝血酶对因子XI的激活作用:含磷脂酰丝氨酸和磷脂酰乙醇胺的磷脂囊泡的刺激作用
Thromb Haemost. 1997 Aug;78(2):834-9.

引用本文的文献

1
A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.一种新型的针对凝血因子IXa的酶联免疫吸附测定法可检测人血浆中的凝血因子IXa。
Res Pract Thromb Haemost. 2024 Feb 5;8(1):102338. doi: 10.1016/j.rpth.2024.102338. eCollection 2024 Jan.
2
The roles of P-selectin in cancer cachexia.P 选择素在癌症恶病质中的作用。
Med Oncol. 2023 Oct 23;40(11):338. doi: 10.1007/s12032-023-02207-2.
3
Temozolomide and Lomustine Induce Tissue Factor Expression and Procoagulant Activity in Glioblastoma Cells In Vitro.
替莫唑胺和洛莫司汀在体外诱导胶质母细胞瘤细胞组织因子表达和促凝血活性。
Cancers (Basel). 2023 Apr 18;15(8):2347. doi: 10.3390/cancers15082347.
4
The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors.血小板对 COVID-19 全病程及持续激活因素肺微循环的影响。
Front Immunol. 2022 Sep 28;13:955654. doi: 10.3389/fimmu.2022.955654. eCollection 2022.
5
Alcohol functionality in the fatty acid backbone of sphingomyelin guides the inhibition of blood coagulation.鞘磷脂脂肪酸主链中的醇官能团可抑制血液凝固。
RSC Adv. 2021 Jan 15;11(6):3390-3398. doi: 10.1039/d0ra09218e. eCollection 2021 Jan 14.
6
Stoichiometric analysis reveals a unique phosphatidylserine binding site in coagulation factor X.化学计量分析揭示凝血因子 X 中存在独特的磷脂酰丝氨酸结合位点。
J Thromb Haemost. 2022 Mar;20(3):600-604. doi: 10.1111/jth.15620. Epub 2021 Dec 17.
7
Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.通过联合实验和计算方法揭示凝血因子的膜结合模型。
Thromb Haemost. 2021 Sep;121(9):1122-1137. doi: 10.1055/s-0040-1722187. Epub 2021 Jul 2.
8
Phosphatidylserine and phosphatidylethanolamine regulate the structure and function of FVIIa and its interaction with soluble tissue factor.磷脂酰丝氨酸和磷脂酰乙醇胺调节 FVIIa 的结构和功能及其与可溶性组织因子的相互作用。
Biosci Rep. 2021 Feb 26;41(2). doi: 10.1042/BSR20204077.
9
Phosphatidylethanolamine and Phosphatidylserine Synergize To Enhance GAS6/AXL-Mediated Virus Infection and Efferocytosis.磷脂酰乙醇胺和磷脂酰丝氨酸协同作用增强 GAS6/AXL 介导的病毒感染和胞吐作用。
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.02079-20.
10
Phosphatidylethanolamine-phosphatidylserine binding synergy of seven coagulation factors revealed using Nanodisc arrays on silicon photonic sensors.利用硅基光学生物传感器上的纳米盘阵列揭示七种凝血因子的磷脂酰乙醇胺-磷脂酰丝氨酸结合协同作用。
Sci Rep. 2020 Oct 15;10(1):17407. doi: 10.1038/s41598-020-73647-3.